Pierce N F, Sack R B, Sircar B K
J Infect Dis. 1977 Jun;135(6):888-96. doi: 10.1093/infdis/135.6.888.
Protection against experimental cholera after immunization with a purified glutaraldehyde toxoid given subcutaneously (sc), orally, or by a combined sc-oral sequence was compared in dogs. The protection induced by toxoid appeared to be entirely due to antitoxin. Repeated sc immunization with precipitated toxoid resulted in 77% protection at two weeks but no protection at four months. Protection after sc immunization correlated with titers of antitoxin in serum and appeared to result entirely from serum-derived antibody. In contrast, immunization by the sc-oral sequence resulted in prolonged protection (74% at two weeks, P=0.04; 100% after four months, P=0.004; and 57% after eight months, P=0.01) that was not related to the low serum antitoxin titers achieved. This sequence was effective only if the oral booster was given in divided doses. Immunization by oral priming and boosting was ineffective. These results suggest that the sc-oral sequence of immunization is an efficient means of stimulating the enteric immune response to nonreplicating protein antigens and may provide an improved approach to immunization against cholera.
在犬类中比较了皮下注射(sc)、口服或采用皮下-口服联合免疫程序接种纯化戊二醛类毒素后对实验性霍乱的保护作用。类毒素诱导的保护作用似乎完全归因于抗毒素。用沉淀类毒素反复进行皮下免疫在两周时产生了77%的保护作用,但在四个月时没有保护作用。皮下免疫后的保护作用与血清中抗毒素滴度相关,似乎完全由血清来源的抗体所致。相比之下,皮下-口服免疫程序产生了持久的保护作用(两周时为74%,P=0.04;四个月后为100%,P=0.004;八个月后为57%,P=0.01),这与所达到的低血清抗毒素滴度无关。该免疫程序只有在口服加强剂量分多次给予时才有效。口服初次免疫和加强免疫无效。这些结果表明,皮下-口服免疫程序是刺激对非复制性蛋白质抗原的肠道免疫反应的有效手段,可能为霍乱免疫提供一种改进方法。